Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.59 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.47 |
| ▸ | TERT | O14746 | 3/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.47 |
| ▸ | PPARG | P37231 | 3/20 | 0.47 |
| ▸ | PPARD | Q03181 | 3/20 | 0.47 |
| ▸ | PPARA | Q07869 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | FABP4 | P15090 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5174206 | 1.00 | FAAH (0.59) | FAAHTRPV1TSHREPHX2TERT | |
| SCHEMBL5174196 | 1.00 | FAAH (0.59) | FAAHTRPV1TSHREPHX2TERT | |
| SCHEMBL5171649 | 1.00 | FAAH (0.59) | FAAHTRPV1TSHREPHX2TERT | |
| Hydrochloric Acid SCHEMBL20840339 | 0.98 | FAAH (0.57) | FAAHTRPV1TSHREPHX2TERT | |
| SCHEMBL95389 | 0.89 | ADH1C (0.52) | FAAHTRPV1TSHR | |
| SCHEMBL5175186 | 0.89 | ADH1C (0.52) | FAAHTRPV1TSHR | |
| SCHEMBL3962903 | 0.89 | ADH1C (0.52) | FAAHTRPV1TSHR | |
| SCHEMBL276871 | 0.89 | ADH1C (0.52) | FAAHTRPV1TSHR | |
| SCHEMBL277587 | 0.89 | ADH1C (0.52) | FAAHTRPV1TSHR | |
| SCHEMBL55195 | 0.89 | ADH1C (0.52) | FAAHTRPV1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8299003-B2 | Composition comprising a sulfur-containing, phosphorus-containing compound, and/or its salt, and uses thereof | AFTON CHEMICAL CORPORATION (US) | 2012-10-30 | — | — | US | disclosed |
| EP-1832646-A1 | Lubricant composition | Afton Chemical Corporation (US) | 2007-09-12 | — | — | EP | disclosed |
| US-20070142249-A1 | Composition comprising a sulfur-containing, phosphorus-containing compound, and/or its salt, and uses threof | AFTON CHEMICAL CORPORATION | 2007-06-21 | — | — | US | disclosed |
| US-20070142659-A1 | Sulfur-containing, phosphorus-containing compound, its salt, and methods thereof | AFTON CHEMICAL CORPORATION | 2007-06-21 | — | — | US | disclosed |
| US-20070142248-A1 | Viscosity index improver, and a sterically hindered sulfur-containing, phosphorus-containing compound and a salt of the thiophosphate | AFTON CHEMICAL CORPORATION | 2007-06-21 | — | — | US | disclosed |
| US-20070142237-A1 | Lubricant composition | AFTON CHEMICAL CORPORATION | 2007-06-21 | — | — | US | disclosed |
| EP-1785476-A1 | Lubricant composition | Afton Chemical Corporation (US) | 2007-05-16 | — | — | EP | disclosed |
| EP-1785471-A1 | A salt of sulfur-containing, phosphorus-containing compound, and method of preparation thereof | Afton Chemical Corporation (US) | 2007-05-16 | — | — | EP | disclosed |
| EP-1785475-A1 | A gear additive composition | Afton Chemical Corporation (US) | 2007-05-16 | — | — | EP | disclosed |
| EP-1785474-A1 | Lubricant composition | Afton Chemical Corporation (US) | 2007-05-16 | — | — | EP | disclosed |
| EP-1785470-A2 | Composition comprising a sulfur-containing, phosphorus-containing compound, and/or its salt, and uses thereof | Afton Chemical Corporation (US) | 2007-05-16 | — | — | EP | disclosed |
| US-20070105729-A1 | Gear additive composition | AFTON CHEMICAL CORPORATION | 2007-05-10 | — | — | US | disclosed |
| US-20070105728-A1 | Lubricant composition | AFTON CHEMICAL CORPORATION | 2007-05-10 | — | — | US | disclosed |
| EP-0445243-B1 | A METHOD OF PREPARING MONOTHIOPHOSPHORIC ACID BY SULFURIZING A PHOSPHITE IN THE PRESENCE OF AN AMIDE | LUBRIZOL CORP (US) | 1995-02-15 | — | — | EP | disclosed |
| EP-0445243-A1 | A METHOD OF PREPARING MONOTHIOPHOSPHORIC ACID BY SULFURIZING A PHOSPHITE IN THE PRESENCE OF AN AMIDE. | LUBRIZOL CORP (US) | 1991-09-11 | — | — | EP | disclosed |
| WO-1991004979-A1 | A METHOD OF PREPARING MONOTHIOPHOSPHORIC ACID BY SULFURIZING A PHOSPHITE IN THE PRESENCE OF AN AMIDE | THE LUBRIZOL CORPORATION (US) | 1991-04-18 | — | — | WO | disclosed |
| US-4997968-A | Sulfiding phosphonate | THE LUBRIZOL CORPORATION (US) | 1991-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070142248-A1 | Viscosity index improver, and a sterically hindered sulfur-containing, phosphorus-containing compound and a salt of the thiophosphate | PSPH, PHOSPHO1, SOST | FAAH 4319/4885TRPV1 2651/4885TSHR 760/4885 |
| US-20070142249-A1 | Composition comprising a sulfur-containing, phosphorus-containing compound, and/or its salt, and uses threof | SRSF9, SLC6A9, SLC9A3 | FAAH 4765/4885TRPV1 1478/4885TSHR 1510/4885 |
| US-20070142659-A1 | Sulfur-containing, phosphorus-containing compound, its salt, and methods thereof | TST, PSPH, SCLY | FAAH 4488/4885TRPV1 2341/4885TSHR 4047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.